Wendy Goldstein, a health care regulatory lawyer and former member of Epstein Becker & Green’s board of directors, has left to become a partner at Cooley. Goldstein chaired Epstein’s health care and life science practice steering committee and the firm’s pharmaceutical industry health regulatory group. She counsels on research, manufacture, promotion, distribution, pricing and import/export of pharmaceuticals, biologics and medical devices.
Cooley CEO Joe Conroy said Goldstein and Cooley have worked for some of the same clients. Conroy said Goldstein’s move didn’t reflect a move to flee Epstein but to join "a bigger and better platform that allows her to sell a broad array of services." Goldstein was not available to comment Monday.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
